Events > Legal & IP Considerations for Healthcare & Life Science Exporters
row-start col-md-7 #top-section top-section new-section

Legal & IP Considerations for Healthcare & Life Science Exporters

Friday, 19 March 2021 10:00 am to 11:00 am


Join this practical webinar to hear from DIT South West, Medilink South West, NJ Akers & Co. and GL Law, as they discuss the legal considerations and best approaches for Healthcare and Life Science companies selling and trading internationally.


Register Your Place Now - Click Here


What will I learn?

Despite international opportunities, UK companies need to take a diligent approach to mitigate both exposure and risk when exporting; a robust legal and IP strategy goes a significant way to minimise these risks.

Join this free webinar to learn more from our experts about the above considerations and more.


Please scroll down the page to see the list of speakers.


Who is this event for?

This webinar is both relevant for new and existing exporters in the South West engaged in pharmaceuticals, medical devices, biotech, CROs, medtech and service/training providers.


Why export?

Life science manufacturing makes a significant contribution to the UK economy, accounting for 11.4% (£30.7bn) of all manufactured goods exported. Due to its strong global reputation, there is a high demand from international buyers who are keen to access UK expertise, experience, and innovative solutions. The UK has a strong global reputation for its 70-year experience of running the National Health Service, with a reputation for clinical excellence and high-quality private-sector delivery. 

For new exporters, it is recommended you identify and protect IP before exporting to a new market and undertake the relevant level of due diligence to minimise risk when you start to export. Wider legal considerations, such as contracting, partnership agreements, NDAs and data protection laws must also be prescribed detailed attention. New markets may have their own unique legal and IP jurisdictions, requiring different approaches to existing practice for UK exporters. 


Register Your Place Now - Click Here


Please Note: We will send you details of the online platform and login details prior to the event.


This event is organised in association with the Western Gateway Partnership.


Business West (delivery partner for the Department for International Trade)  is committed to providing a professional, friendly, safe and welcoming environment for all participants at its events. Inappropriate behaviour on video, audio & chat facilities will not be tolerated during any portion of a meeting or event. It will be at the sole discretion of the host/facilitator to immediately expel any participants from the event if their behaviour is deemed to be inappropriate and/or offensive.

Privacy Policy

We take your data very seriously and are committed to the privacy and security of it. This event is organised by Business West, delivery partner for The Department of International Trade for the SW,  their privacy policies are available at DIT Personal Information Charter.

row-end col-sm-12 col-md-5
row-start col-xs-12 colour-section row-end


Jamie Shaw, Healthcare Life Science Sector Specialist at DIT - Western Gateway

Jamie comes with significant private sector experience where most recently he was based overseas as an International Account Manager for China’s largest medical device manufacturer, Mindray. Jamie worked with overseas subsidiaries within the business and supported/implemented new direct/indirect sales channels in a number of territories; working with both public and private sector healthcare institutions.


Professor Richard Luxton, Director, Institute of Bio-Sensing Technology, University of the West of England

Richard Luxton studied clinical chemistry in the National Health Service for thirteen years at the Bristol Royal Infirmary before moving to the Institute of Neurology in London to study for a PhD in neuro-immunology, investigating antibody affinity in the CSF of patients with multiple sclerosis.

At the University of the West of England he focused his research in the area of developing new rapid detection technologies for point of care diagnostics, environmental analysis, food safety and homeland defence applications.

He has launched the South West Biomedical Innovation Network in 2011, Medilink South West in 2012 (of which he is currently the company's Chairman), a European funded Business Technology Centre in 2014, and a new Health Technology Hub at the University of the West of England in 2018.


Graeme McCallum, Patent & Trade Mark Attorney at NJ Akers & Co

Graeme McCallum is a qualified UK and European patent attorney and trade mark attorney and an IP Litigator. He has over 20 years experience helping clients to protect and enforce their intellectual property rights.

Graeme has a broad range of experience in different medical related technologies, including surgical instruments, stents and grafts, catheters, NMR imaging, drug delivery systems and anti-bacterial compositions as well as more general healthcare technologies such as monitors, beds and mattresses.

Graeme has substantial experience of assisting start-ups and SMEs, as well as managing the IP portfolios of multi-national corporations. He assists clients to extract maximum value from their innovations and to ensure that their IP strategies are aligned with their business strategies and work to support the business. He has particular expertise in advising clients on brand protection and on high value and standards related patent cases.


Paul Hardman – Director, Head of Corporate and Commercial – GL Law

Paul Hardman is a Director and Head of the Corporate and Commercial department; he became a co-owner of the firm in 2012.

With over 30 years’ experience, Paul specialises in corporate finance work covering mergers and acquisitions, management buy outs and buy ins, joint venture arrangements and shareholder agreements. He is well regarded by clients for confidently and competently pulling deals together. He is highly skilled in recognising what will work and what has been missed and knowing when to hold firm and when to concede to achieve his client’s goal.

Paul’s team works with clients ranging from start-ups to well-established companies on corporate transactions and commercial contracts matters. The team are regularly recognised in the Legal 500 and Chambers and Partners legal directories.

Paul is a Director of the Business and West of England China Bureau.